• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSIDI TECHNOLOGY, CO., LTD. BOSIDIN FACIAL & BODY PERMANENT HAIR REMOVAL FOR WOMEN; LIGHT BASED OVER-THE-COUNTER HAIR REMOVAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSIDI TECHNOLOGY, CO., LTD. BOSIDIN FACIAL & BODY PERMANENT HAIR REMOVAL FOR WOMEN; LIGHT BASED OVER-THE-COUNTER HAIR REMOVAL Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Burn, Thermal (2530)
Event Date 02/16/2019
Event Type  Injury  
Event Description
I tried to use the product that i bought from (b)(6).The link is (b)(6).However, after i used this device on my face, it felt very painful and my neck was burned up.When we tried to search fda info about this device, there is nothing.Is this product fda approved? the device was bought from (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BOSIDIN FACIAL & BODY PERMANENT HAIR REMOVAL FOR WOMEN
Type of Device
LIGHT BASED OVER-THE-COUNTER HAIR REMOVAL
Manufacturer (Section D)
BOSIDI TECHNOLOGY, CO., LTD.
MDR Report Key8470770
MDR Text Key140603930
Report NumberMW5085427
Device Sequence Number1
Product Code OHT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age28 YR
-
-